FrancophonIA/ELRC3.0 huggingface dataset:
English: You may need to have blood checks if you take: potassium supplements salt substitutes containing potassium potassium sparing medicines or other diuretics (water tablets) some laxatives medicines for the treatment of gout therapeutic vitamin D supplements medicines to control heart rhythm medicines for diabetes (oral agents or insulins) carbamazepine (a medicine for the treatment of epilepsy).
Icelandic: ▪ saltuppbót sem inniheldur kalíum ▪ kalíumsparandi lyf eða önnur þvagræsilyf (vatnslosandi töflur) ▪ sum hægðalyf ▪ lyf við þvagsýrugigt ▪ lækningalega skammta af D-vítamíni ▪ lyf sem hafa áhrif á hjartsláttartíðni ▪ lyf við sykursýki (til inntöku eða insúlín).
English: Excipient with known effect: Each tablet contains 26.65 mg of lactose (as lactose monohydrate).
Icelandic: Hver tafla inniheldur 26,65 mg af laktósa (sem laktósamónóhýdrat).
English: Dual blockade of the renin-angiotensin-aldosterone system (RAAS): there is evidence that the concomitant use of ACE-inhibitors, angiotensin II receptor blockers or aliskiren increases the risk of hypotension, hyperkalaemia and decreased renal function (including acute renal failure).
Icelandic: Tvöföld hömlun á renín-angíótensín-aldósterónkerfinu: vísbendingar eru um að samhliðanotkun ACE hemla, angíótensín II viðtakablokka eða aliskirens auki hættu á blóðþrýstingslækkun, blóðkalíumhækkun og skerðingu á nýrnastarfsemi (þ.m.t. bráðri nýrnabilun).
English: Medicinal products affected by serum potassium disturbances: periodic monitoring of serum potassium is recommended when Karvezide is administered with medicinal products affected by serum potassium disturbances (e.g. digitalis glycosides, antiarrhythmics).
Icelandic: Ráðlagt er að mæla kalíum í sermi reglulega þegar Karvezide er notað samtímis lyfjum sem kalíumröskun í sermi hefur áhrif á (t.d. dígitalisglýkósíðum og lyfjum við hjartsláttaróreglu).
English: Potassium-sparing diuretics, potassium supplements or potassium-containing salts substitutes should be co-administered cautiously with Karvezide (see section 4.5).
Icelandic: Gæta skal varúðar við samtímis notkun kalíumsparandi þvagræsilyfja, kalíumuppbótar eða saltuppbótar sem inniheldur kalíum og Karvezide (sjá kafla 4.5).
English: Renal impairment and kidney transplantation: when Karvezide is used in patients with impaired renal function, a periodic monitoring of potassium, creatinine and uric acid serum levels is recommended.
Icelandic: Þegar Karvezide er gefið sjúklingum með skerta nýrnastarfsemi er mælt með reglulegri mælingu á gildum kalíums, kreatíníns- og þvagsýru í sermi.
English: Non-melanoma skin cancer: based on available data from epidemiological studies, cumulative dose dependent association between HCTZ and NMSC has been observed (see also sections 4.4 and 5.1).
Icelandic: Byggt á fyrirliggjandi upplýsingum úr faraldsfræðilegum rannsóknum hafa komið í ljós skammtaháð tengsl við uppsafnaðan skammt milli hýdróklórtíazíðs og húðkrabbameins sem ekki er sortuæxli (sjá einnig kafla 4.4 og 5.1).
English: If you get any of the above symptoms or get short of breath, stop taking Karvezide and contact your doctor immediately.
Icelandic: Ef þú færð eitthvert ofantaldra einkenna eða ef þú átt erfitt með öndun skaltu hætta töku
English: Because no information is available regarding the use of Karvezide during breast-feeding, Karvezide is not recommended and alternative treatments with better established safety profiles during breastfeeding are preferable, especially while nursing a newborn or preterm infant.
Icelandic: Þar sem engar upplýsingar liggja fyrir um notkun Karvezide meðan á brjóstagjöf stendur er ekki mælt með notkun Karvezide hjá konum sem hafa barn á brjósti.
English: Karvezide 300 mg/12.5 mg tablets.
Icelandic: Karvezide 300 mg/12,5 mg töflur.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON
Icelandic: Lýsing á útliti Karvezide og pakkningastærðir
English: You should also tell your doctor:  if you are on a low-salt diet if you have signs such as abnormal thirst, dry mouth, general weakness, drowsiness, muscle pain or cramps, nausea, vomiting, or an abnormally fast heart beat which may indicate an excessive effect of hydrochlorothiazide (contained in Karvezide) if you experience an increased sensitivity of the skin to the sun with symptoms of sunburn (such as redness, itching, swelling, blistering) occurring more quickly than normal if you are going to have an operation (surgery) or be given anaesthetics if you have changes in your vision or pain in one or both of your eyes while taking Karvezide.
Icelandic: ▪ ef þú ert á saltsnauðu fæði ▪ ef þú finnur fyrir einkennum eins og óeðlilegum þorsta, munnþurrki, almennu þróttleysi, sljóleika, vöðvaverkjum eða sinadrætti, ógleði, uppköstum eða óeðlilega hröðum hjartslætti, en það getur verið merki um of mikil áhrif af hýdróklórtíazíði (innihaldsefni í Karvezide) ▪ ef þú finnur fyrir að húðin verður viðkvæmari fyrir sólinni með einkennum sólbruna (svo sem roða, kláða, þrota eða blöðrumyndun) sem á sér stað hraðar en venjulega ▪ ef þú þarft að fara í skurðaðgerð eða svæfingu.
English: You should also tell your doctor:  if you are on a low-salt diet if you have signs such as abnormal thirst, dry mouth, general weakness, drowsiness, muscle pain or cramps, nausea, vomiting, or an abnormally fast heart beat which may indicate an excessive effect of hydrochlorothiazide (contained in Karvezide) if you experience an increased sensitivity of the skin to the sun with symptoms of sunburn (such as redness, itching, swelling, blistering) occurring more quickly than normal  if you are going to have an operation (surgery) or be given anaesthetics if you have changes in your vision or pain in one or both of your eyes while taking Karvezide.
Icelandic: ▪ ef þú ert á saltsnauðu fæði ▪ ef þú finnur fyrir einkennum eins og óeðlilegum þorsta, munnþurrki, almennu þróttleysi, sljóleika, vöðvaverkjum eða sinadrætti, ógleði, uppköstum eða óeðlilega hröðum hjartslætti, en það getur verið merki um of mikil áhrif af hýdróklórtíazíði (innihaldsefni í Karvezide) ▪ ef þú finnur fyrir að húðin verður viðkvæmari fyrir sólinni með einkennum sólbruna (svo sem roða, kláða, þrota eða blöðrumyndun) sem á sér stað hraðar en venjulega ▪ ef þú þarft að fara í skurðaðgerð eða svæfingu.
English: Common side effects (may affect up to 1 in 10 people): nausea/vomiting abnormal urination fatigue dizziness (including when getting up from a lying or sitting position) blood tests may show raised levels of an enzyme that measures the muscle and heart function (creatine kinase) or raised levels of substances that measure kidney function (blood urea nitrogen, creatinine).
Icelandic: ▪ ógleði/uppköst ▪ óeðlileg þvaglát ▪ þreyta ▪ svimi (þar með talið þegar risið er upp úr liggjandi eða sitjandi stöðu) ▪ blóðrannsóknir geta sýnt aukið magn ensíms (kreatínkínasa), sem er mælikvarði á vöðva- og hjartastarfsemi eða aukið magn efna (blóðnitur og kreatínín í blóði) sem eru mælikvarði á starfsemi nýrna.
English: What Karvezide contains  The active substances are irbesartan and hydrochlorothiazide.
Icelandic: Karvezide inniheldur ▪ Virku innihaldsefnin eru irbesartan og hýdróklórtíazíð.
English: Uncommon side effects -may affect up to 1 in 100 people): diarrhoea low blood pressure fainting heart rate increased flushing swelling sexual dysfunction (problems with sexual performance) blood tests may show lowered levels of potassium and sodium in your blood.
Icelandic: Sjaldgæfar aukaverkanir (geta komið fyrir hjá allt að 1 af hverjum 100 einstaklingum): ▪ niðurgangur ▪ lágur blóðþrýstingur ▪ yfirlið ▪ hraðari hjartsláttur ▪ andlitsroði ▪ bólga ▪ minnkuð kyngeta (vandamál við kynlíf) ▪ hugsanlega sýna blóðrannsóknir kalíum- og natríumskort.
English: The following changes, observed in rats and macaques receiving the irbesartan/hydrochlorothiazide combination at 10/10 and 90/90 mg/kg/day, were also seen with one of the two medicinal products alone and/or were secondary to decreases in blood pressure (no significant toxicologic interactions were observed):  kidney changes, characterized by slight increases in serum urea and creatinine, and hyperplasia/hypertrophy of the juxtaglomerular apparatus, which are a direct consequence of the interaction of irbesartan with the renin-angiotensin system;  slight decreases in erythrocyte parameters (erythrocytes, haemoglobin, haematocrit);  stomach discoloration, ulcers and focal necrosis of gastric mucosa were observed in few rats in a 6 months toxicity study at irbesartan 90 mg/kg/day, hydrochlorothiazide 90 mg/kg/day, and irbesartan/hydrochlorothiazide 10/10 mg/kg/day.
Icelandic: Eftirtaldar breytingar, sem komu fram í rottum sem fengu 10/10 mg/kg/sólarhring af samsetningu irbesartans/hýdróklórtíazíðs og makakíöpum sem fengu 90/90 mg/kg/sólarhring, komu einnig fram þegar annað af þessum tveimur lyfjum var notað eitt sér og/eða voru vegna áhrifa lágs blóðþrýstings (engar marktækar milliverkanir komu fram sem höfðu eiturhrif):
English: Karvezide with food and drink Karvezide can be taken with or without food.
Icelandic: Karvezide má taka með eða án matar.
English: Due to the hydrochlorothiazide component, Karvezide is not recommended for patients with severe renal dysfunction (creatinine clearance < 30 ml/min).
Icelandic: Ekki er ráðlagt að gefa Karvezide sjúklingum með verulega skerta nýrnastarfsemi (kreatínín úthreinsun < 30 ml/mín.)
English: Other medicines and Karvezide
Icelandic: Karvezide og pakkningastærðir
English: Karvezide 150 mg/12.5 mg tablets.
Icelandic: Karvezide 150 mg/12,5 mg töflur.
English: Excipient with known effect: Each tablet contains 65.8 mg of lactose (as lactose monohydrate).
Icelandic: Hver tafla inniheldur 65,8 mg af laktósa (sem laktósamónóhýdrat).
English: Each film-coated tablet of Karvezide 300 mg/25 mg contains 300 mg irbesartan and 25 mg hydrochlorothiazide.
Icelandic: Hver filmuhúðuð tafla af Karvezide 300 mg/25 mg inniheldur 300 mg af irbesartani og 25 mg af hýdróklórtíazíði.
English: Each film-coated tablet contains 300 mg of irbesartan and 25 mg of hydrochlorothiazide.
Icelandic: Hver filmuhúðuð tafla inniheldur 300 mg af irbesartani og 25 mg af hýdróklórtíazíði.
English: In addition to the side effects listed above, chest pain, severe allergic reactions (anaphylactic shock) and decrease in the number of platelets (a blood cell essential for the clotting of the blood) have also been reported.
Icelandic: Aukaverkanir sem tengjast irbesartani einu og sér Auk framangreindra aukaverkana hefur einnig verið tilkynnt um verk fyrir brjósti, veruleg ofnæmisviðbrögð (bráðaofnæmislost) og fækkun blóðflagna (blóðfrumur sem eru bráðnauðsynlegar fyrir storknun blóðs).
English: Excipient with known effect: Each film-coated tablet contains 89.5 mg of lactose (as lactose monohydrate).
Icelandic: Hver tafla inniheldur 89,5 mg af laktósa (sem laktósamónóhýdrat).
English: Based on its pharmacodynamic properties, Karvezide is unlikely to affect the ability to drive and use machine.
Icelandic: Karvezide er talið ólíklegt að það hafi áhrif á hæfni til aksturs og notkunar véla.
English: Karvezide 150 mg/12.5 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets.
Icelandic: Karvezide 150 mg/12,5 mg töflur eru í þynnupökkum með 14, 28, 56 eða 98 töflum.
English: Karvezide 300 mg/25 mg film-coated tablets are supplied in blister packs of 14, 28, 30, 56, 84, 90 or 98 film-coated tablets.
Icelandic: Karvezide 300 mg/25 mg filmuhúðaðar töflur fást í þynnupökkum með 14, 28, 30, 56, 84, 90 eða 98 filmuhúðuðum töflum.
English: Excipient with known effect: Each film-coated tablet contains 53.3 mg of lactose (as lactose monohydrate).
Icelandic: Hver tafla inniheldur 53,3 mg af laktósa (sem laktósamónóhýdrat).
English: Karvezide 300 mg/12.5 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets.
Icelandic: Karvezide 300 mg/12,5 mg töflur eru í þynnupökkum með 14, 28, 56 eða 98 töflum.
English: Each tablet of Karvezide 150 mg/12.5 mg contains 150 mg irbesartan and 12.5 mg hydrochlorothiazide.
Icelandic: Karvezide 150 mg/12,5 mg inniheldur 150 mg af irbesartani og 12,5 mg af hýdróklórtíazíði.
English: What Karvezide looks like and contents of the pack Karvezide 300 mg/25 mg film-coated tablets are pink, biconvex, oval-shaped, with a heart debossed on one side and the number 2788 engraved on the other side.
Icelandic: Karvezide 300 mg/25 mg filmuhúðaðar töflur eru bleik, kúptar, sporöskjulaga með upphleyptri mynd af hjarta á annarri hliðinni og númerið 2788 greypt í hina hliðina.
English: Excipient with known effect: Each film-coated tablet contains 38.5 mg of lactose (as lactose monohydrate).
Icelandic: Hver tafla inniheldur 38,5 mg af laktósa (sem laktósamónóhýdrat).
English: Karvezide 300 mg/25 mg film-coated tablets irbesartan/hydrochlorothiazide
Icelandic: Karvezide 300 mg/25 mg filmuhúðaðar töflur irbesartan/hýdróklórtíazíð
English: EU/1/98/085/008 - 14 tablets EU/1/98/085/004 - 28 tablets EU/1/98/085/005 - 56 tablets EU/1/98/085/010 - 56 x 1 tablets EU/1/98/085/006 - 98 tablets
Icelandic: EU/1/98/085/008 - 14 töflur EU/1/98/085/004 - 28 töflur EU/1/98/085/005 - 56 töflur EU/1/98/085/010 - 56 x 1 töflur EU/1/98/085/006 - 98 töflur
English: Karvezide 150 mg/12.5 mg film-coated tablets are supplied in blister packs of 14, 28, 30, 56, 84, 90 or 98 film-coated tablets.
Icelandic: Karvezide 150 mg/12,5 mg filmuhúðaðar töflur fást í þynnupökkum með 14, 28, 30, 56, 84, 90 eða 98 filmuhúðuðum töflum.
English: Karvezide is a combination of an angiotensin-II receptor antagonist, irbesartan, and a thiazide diuretic, hydrochlorothiazide.
Icelandic: Karvezide inniheldur blöndu af angíótensín-II blokka, irbesartani, og tíazíð þvagræsilyfi, hýdróklórtíazíði.
English: EU/1/98/085/007 - 14 tablets EU/1/98/085/001 - 28 tablets EU/1/98/085/002 - 56 tablets EU/1/98/085/009 - 56 x 1 tablets EU/1/98/085/003 - 98 tablets
Icelandic: EU/1/98/085/007 - 14 töflur EU/1/98/085/001 - 28 töflur EU/1/98/085/002 - 56 töflur EU/1/98/085/009 - 56 x 1 töflur EU/1/98/085/003 - 98 töflur
English: Karvezide 300 mg/12.5 mg film-coated tablets are supplied in blister packs of 14, 28, 30, 56, 84, 90 or 98 film-coated tablets.
Icelandic: Karvezide 300 mg/12,5 mg filmuhúðaðar töflur fást í þynnupökkum með 14, 28, 30, 56, 84, 90 eða 98 filmuhúðuðum töflum.
English: Karvezide 300 mg/12.5 mg film-coated tablets.
Icelandic: Karvezide 300 mg/12,5 mg filmuhúðaðar töflur.
English: Thiazide diuretic-associated azotemia may occur in patients with impaired renal function.
Icelandic: Aukning köfnunarefnis í blóði tengd tíazíð þvagræsilyfinu getur komið fram hjá sjúklingum með skerta nýrnastarfsemi.
English: EU/1/98/085/023 - 14 tablets EU/1/98/085/024 - 28 tablets EU/1/98/085/031 - 30 tablets EU/1/98/085/025 - 56 tablets EU/1/98/085/028 - 56 x 1 tablets EU/1/98/085/026 - 84 tablets EU/1/98/085/034 - 90 tablets EU/1/98/085/027 - 98 tablets
Icelandic: EU/1/98/085/023 - 14 töflur EU/1/98/085/024 - 28 töflur EU/1/98/085/031 - 30 töflur EU/1/98/085/025 - 56 töflur EU/1/98/085/028 - 56 x 1 töflur EU/1/98/085/026 - 84 töflur EU/1/98/085/034 - 90 töflur EU/1/98/085/027 - 98 töflur
English: Karvezide 300 mg/12.5 mg tablets irbesartan/hydrochlorothiazide
Icelandic: Karvezide 300 mg/12,5 mg töflur irbesartan/hýdróklórtíazíð
English: Karvezide 150 mg/12.5 mg film-coated tablets.
Icelandic: Karvezide 150 mg/12,5 mg filmuhúðaðar töflur.
English: Do not take Karvezide  if you are allergic to irbesartan or any of the other ingredients of this medicine (listed in section 6) if you are allergic to hydrochlorothiazide or any other sulfonamide-derived medicines if you are more than 3 months pregnant.
Icelandic: ▪ ef þú ert með ofnæmi fyrir hýdróklórtíazíði eða fyrir einhverjum öðrum lyfjum sem eru súlfonamíðafleiður ▪ ef þú ert gengin með meira en 3 mánuði á meðgöngu.
English: The trough to peak effects measured by cuff during office visits were 68% and 76% for Karvezide 150 mg/12.5 mg and Karvezide 300 mg/12.5 mg, respectively.
Icelandic: Hlutfall lágmarksáhrifa/hámarksáhrifa (trough to peak) var 68% eftir gjöf Karvezide 150 mg/12,5 mg þegar blóðþrýstingur var mældur með manséttumæli hjá sjúklingum við komu á læknastofu, en 76% eftir gjöf Karvezide 300 mg/12,5 mg.
English: Each tablet contains 300 mg of irbesartan and 12.5 mg of hydrochlorothiazide.
Icelandic: Hver tafla inniheldur 300 mg af irbesartani og 12,5 mg af hýdróklórtíazíði.
English: Karvezide 150 mg/12.5 mg tablets irbesartan/hydrochlorothiazide
Icelandic: Karvezide 150 mg/12,5 mg töflur irbesartan/hýdróklórtíazíð
English: EU/1/98/085/011 - 14 tablets EU/1/98/085/012 - 28 tablets EU/1/98/085/029 - 30 tablets EU/1/98/085/013 - 56 tablets EU/1/98/085/014 - 56 x 1 tablets EU/1/98/085/021 - 84 tablets EU/1/98/085/032 - 90 tablets EU/1/98/085/015 - 98 tablets
Icelandic: EU/1/98/085/011 - 14 töflur EU/1/98/085/012 - 28 töflur EU/1/98/085/029 - 30 töflur EU/1/98/085/013 - 56 töflur EU/1/98/085/014 - 56 x 1 töflur EU/1/98/085/021 - 84 töflur EU/1/98/085/032 - 90 töflur EU/1/98/085/015 - 98 töflur
English: EU/1/98/085/016 - 14 tablets EU/1/98/085/017 - 28 tablets EU/1/98/085/030 - 30 tablets EU/1/98/085/018 - 56 tablets EU/1/98/085/019 - 56 x 1 tablets EU/1/98/085/022 - 84 tablets EU/1/98/085/033 - 90 tablets EU/1/98/085/020 - 98 tablets
Icelandic: EU/1/98/085/016 - 14 töflur EU/1/98/085/017 - 28 töflur EU/1/98/085/030 - 30 töflur EU/1/98/085/018 - 56 töflur EU/1/98/085/019 - 56 x 1 töflur EU/1/98/085/022 - 84 töflur EU/1/98/085/033 - 90 töflur EU/1/98/085/020 - 98 töflur
English: Each tablet contains 150 mg of irbesartan and 12.5 mg of hydrochlorothiazide.
Icelandic: Hver tafla inniheldur 150 mg af irbesartani og 12,5 mg af hýdróklórtíazíði.
English: Each tablet of Karvezide 300 mg/12.5 mg contains 300 mg irbesartan and 12.5 mg hydrochlorothiazide.
Icelandic: Hver Karvezide 300 mg/12,5 mg tafla inniheldur 300 mg af irbesartani og 12,5 mg af hýdróklórtíazíði.
English: Each film-coated tablet contains 300 mg of irbesartan and 12.5 mg of hydrochlorothiazide.
Icelandic: Hver filmuhúðuð tafla inniheldur 300 mg af irbesartani og 12,5 mg af hýdróklórtíazíði.
English: What Karvezide looks like and contents of the pack Karvezide 300 mg/12.5 mg film-coated tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2876 engraved on the other side.
Icelandic: Karvezide 300 mg/12,5 mg filmuhúðaðar töflur eru ferskjulituð, kúptar, sporöskjulaga með upphleyptri mynd af hjarta á annarri hliðinni og númerið 2876 greypt í hina hliðina.
English: Each film-coated tablet of Karvezide 300 mg/12.5 mg contains 300 mg irbesartan and 12.5 mg hydrochlorothiazide.
Icelandic: Hver filmuhúðuð tafla af Karvezide 300 mg/12,5 mg inniheldur 300 mg af irbesartani og 12,5 mg af hýdróklórtíazíði.
English: What Karvezide looks like and contents of the pack Karvezide 300 mg/12.5 mg tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2776 engraved on the other side.
Icelandic: Karvezide 300 mg/12,5 mg töflur eru ferskjulitaðar, kúptar, sporöskjulaga með upphleyptri mynd af hjarta á annarri hliðinni og númerið 2776 greypt í hina hliðina.
English: What Karvezide looks like and contents of the pack Karvezide 150 mg/12.5 mg film-coated tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2875 engraved on the other side.
Icelandic: Karvezide 150 mg/12,5 mg filmuhúðaðar töflur eru ferskjulituð, kúptar, sporöskjulaga með upphleyptri mynd af hjarta á annarri hliðinni og númerið 2875 greypt í hina hliðina.
English: Karvezide 150 mg/12.5 mg film-coated tablets irbesartan/hydrochlorothiazide
Icelandic: Karvezide 150 mg/12,5 mg filmuhúðaðar töflur irbesartan/hýdróklórtíazíð
English: (It is also better to avoid Karvezide in early pregnancy - see pregnancy section) if you have severe liver or kidney problems if you have difficulty in producing urine if your doctor determines that you have persistently high calcium or low potassium levels in your blood if you have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren.
Icelandic: ▪ ef læknirinn metur að þú hafir langvarandi há kalsíum eða lág kalíum gildi í blóði ▪ ef þú ert með sykursýki eða skerta nýrnastarfsemi og ert á meðferð með blóðþrýstingslækkandi lyfi sem inniheldur aliskiren.
English: What Karvezide looks like and contents of the pack Karvezide 150 mg/12.5 mg tablets are peach, biconvex, oval-shaped, with a heart debossed on one side and the number 2775 engraved on the other side.
Icelandic: Karvezide 150 mg/12,5 mg töflur eru ferskjulitaðar, kúptar, sporöskjulaga með upphleyptri mynd af hjarta á annarri hliðinni og númerið 2775 greypt í hina hliðina.
English: Karvezide 300 mg/12.5 mg film-coated tablets irbesartan/hydrochlorothiazide
Icelandic: Karvezide 300 mg/12,5 mg filmuhúðaðar töflur irbesartan/hýdróklórtíazíð
English: Warnings and precautions Talk to your doctor before taking Karvezide and if any of the following apply to you: if you get excessive vomiting or diarrhoea if you suffer from kidney problems or have a kidney transplant
Icelandic: Karvezide snemma á meðgöngu - sjá kaflann um meðgöngu) ▪ ef þú ert með alvarlega lifrar- eða nýrnasjúkdóma ▪ ef þú átt í erfiðleikum með þvaglát
English: Other antihypertensive agents: the antihypertensive effect of Karvezide may be increased with the concomitant use of other antihypertensive agents.
Icelandic: Blóðþrýstingslækkandi áhrif Karvezide geta aukist við samtímis notkun annarra blóðþrýstingslækkandi lyfja.
English: Peak plasma concentration occurs at 1.5-2 hours after oral administration for irbesartan and 1-2.5 hours for hydrochlorothiazide.
Icelandic: Hámarksplasmaþéttni næst 1,5-2 klst. eftir inntöku irbesartans og 12,5 klst. eftir inntöku hýdróklórtíazíðs.
English: When clinically appropriate direct change from monotherapy to the fixed combinations may be considered:  Karvezide 150 mg/12.5 mg may be administered in patients whose blood pressure is not adequately controlled with hydrochlorothiazide or irbesartan 150 mg alone;  Karvezide 300 mg/12.5 mg may be administered in patients insufficiently controlled by irbesartan 300 mg or by Karvezide 150 mg/12.5 mg.  Karvezide 300 mg/25 mg may be administered in patients insufficiently controlled by Karvezide 300 mg/12.5 mg.
Icelandic: ▪ Karvezide 300 mg/12,5 mg má gefa sjúklingum ef 300 mg af irbesartani eða Karvezide 150 mg/12,5 mg reynist ekki nægjanlegt til að ná stjórn á blóðþrýstingi.
English: Please contact your doctor.
Icelandic: Vinsamlega hafðu samband við lækninn.
English: If this happens, your doctor will need to examine you as soon as possible.
Icelandic: Ef þetta gerist, þarf læknirinn að skoða þig eins fljótt og auðið er.
English: • It is important that your hands and the items you use be as clean as possible
Icelandic: Það er mikilvægt að hendurnar og það sem notað er sé eins hreint og mögulegt er.
English: • This may take up to 5 weeks.
Icelandic: Þetta getur tekið allt að 5 vikur.
English: In your body:
Icelandic: Í líkamanum:
English: Tres Cantos E-28760 Madrid Spain
Icelandic: Tres Cantos E-28760 Madrid Spánn
English: They will supervise your first injection.
Icelandic: Þeir fylgjast með fyrstu inndælingunni hjá þér.
English: Zone Industrielle de l'Ouriettaz CH-1170 Aubonne Switzerland
Icelandic: Zone Industielle de l'Ouriettaz CH-1170 Aubonne Sviss
English: • Inject under the skin, as you were taught.
Icelandic: Sprautaðu undir húð eins og þér hefur verið kennt.
English: The doctor might ask you to stop using Pergoveris.
Icelandic: Verið getur að læknirinn biðji þig að hætta að nota Pergoveris.
English: • A good place is a clean table or kitchen surface
Icelandic: • Hentugur staður er hreint borð eða vinnusvæði í eldhúsi
English: Follow the instructions exactly, as it may differ from your past experience.
Icelandic: Fylgdu leiðbeiningunum nákvæmlega þar sem þær geta verið öðruvísi en þú hefur vanist.
English: Get together everything you need and lay them out
Icelandic: Safnaðu saman öllu sem þú þarft og breiddu úr því:
English: ATC code: G03GA30.
Icelandic: G03GA30.
English: It most often occurs after hormonal treatment has been discontinued and reaches its maximum at about seven to ten days following treatment.
Icelandic: Það kemur oftast fram eftir að hormónameðferð er lokið og nær hámarki sjö til tíu dögum eftir meðferð.